GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 1919 - Safeguarding America's Pharmaceuticals Act; provisions related to supply chain security H.R. 6584 - Verifying Authority and Legality in Drug Compounding Act; provisions relating to drug compounding H.R. 1248 - Family Health Care Flexibility Act; provisions relating to reimbursement of OTC drugs under flexible spending and health savings accountsS. 957 - Drug Supply Chain Security Act; provisions related to supply chain security S. 1165 - Access to Appropriate Immunizations for Veterans Act of 2013; provisions related to extending VA performance measure to include all federally recommended vaccine S. 610 - Family Health Care Flexibility Act; provisions relating to reimbursement of OTC drugs under flexible spending and health savings accounts Implementation issues relating to the Patient Protection and Affordable Care Act (PPACA) (Public Law 111-148), including Standards Related to Essential Health Benefits, Actuarial Value, and Accreditation rulemaking FDA accelerated approval policy issues Comparative effectiveness policy issues Biopharmaceutical innovation policy issues Pharmaceutical supply chain security issues 340B prescription drug policy issues FDA special medical use; issues related to limited population antibacterial drug approval pathway
| Lobbyist | Covered position, as disclosed |
|---|---|
| GARY HEIMBERG | — |
| JOSEPH MCGOWAN | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| KIMBERLY A WILLIAMS | — |
Trade (domestic/foreign) TRD
Trans-Pacific Strategic Economic Partnership Agreement (TPP); provisions related to intellectual property, market access and public health issues Transatlantic Trade and Investment Partnership (TTIP); provisions related to market access intellectual property, regulatory harmonization and other issuesIndia innovation, IP and market access issues International market access and intellectual property issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHIRA KILCOYNE | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
Taxation/Internal Revenue Code TAX
H.R. 475 - To amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccines S. 391 - To amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccinesTemporary duty suspension for preparations, such as tablets or chewing gum, intended to assist smokers to stop smoking (provided for in subheading 2106.90.99)
| Lobbyist | Covered position, as disclosed |
|---|---|
| GARY HEIMBERG | — |
| JOSEPH MCGOWAN | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| KIMBERLY A WILLIAMS | — |
Copyright/Patent/Trademark CPT
S. 214 - The Preserve Access to Affordable Generics Act; provisions relating to patent settlements S. 504 - Fair and Immediate Release of Generic Drugs Act; provisions related to patent settlements Biopharmaceutical innovation policy issues Biologics data protection issuesCounterfeit drug issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| GARY HEIMBERG | — |
| JOSEPH MCGOWAN | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| KIMBERLY A WILLIAMS | — |
Medicare/Medicaid MMM
H.R. 351 - Protecting Seniors' Access to Medicare Act of 2013 H.R. 928 - Medicare Prescription Drug Savings and Choice Act of 2013; provisions related to Medicare Part D S. 117 - Medicare Prescription Drug Price Negotiation Act of 2013 S. 351 - Protecting Seniors' Access to Medicare Act of 2013S. 408 - Medicare Prescription Drug Savings and Choice Act of 2013; provisions related to Medicare Part D S. 740 - Medicare Drug Savings Act of 2013; provisions related to Part D issues Dual eligibles coordination policy issues Deficit reduction policy issues related to Medicare Medicaid Program, Covered Outpatient Drugs rulemaking Implementation Issues relating to the Physician Payment Sunshine Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| GARY HEIMBERG | — |
| JOSEPH MCGOWAN | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| KIMBERLY A WILLIAMS | — |
Budget/Appropriations BUD
H.R. 2410 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014; provisions relating to FDA regulation and funding, sequestration, drug importation
| Lobbyist | Covered position, as disclosed |
|---|---|
| GARY HEIMBERG | — |
| JOSEPH MCGOWAN | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| KIMBERLY A WILLIAMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.